Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $160.48 USD
Change Today +0.24 / 0.15%
Volume 391.8K
UTHR On Other Exchanges
Symbol
Exchange
Frankfurt
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Martine A. Rothblatt Ph.D., MBA, J.D.

Founder, Chairman and Co-Chief Executive Officer,United Therapeutics Corporation
AgeTotal Calculated CompensationThis person is connected to 33 board members in 4 different organizations across 4 different industries.

See Board Relationships
60$33,214,929
As of Fiscal Year 2014

Background*

Dr. Martine A. Rothblatt, Ph.D., MBA, J.D. founded United Therapeutics Corporation in 1996 and has also been its Chairman and Co-Chief Executive Officer since 1996 and January 1, 2015 respectively. Dr. Rothblatt serves as the Chairman, President and Chief Executive Officer of Lung Rx Inc (also known as Lung LLC). Dr. Rothblatt served as the Chief Executive Officer of Therapeutics Corporation from 1996 to December 31, 2014. She is a communications technologist and medical ...

Read Full Background

Corporate Headquarters*

1040 Spring Street
Silver Spring, Maryland 20910

United States

Phone: 301-608-9292
Fax: 301-608-9291

Board Members Memberships*

Chairman, Chief Executive Officer and President
Director
1996-Present
Founder, Chairman and Co-Chief Executive Officer

Education*

JD 1981
University of California-Los Angeles
MBA 1981
University of California-Los Angeles
PhD
Queen Mary

Other Affiliations*

Annual Compensation*

Salary$1,024,524
Total Annual Compensation$1,024,524

Stock Options*

All Other Compensation$23,263
Exercised Options551,488
Exercised Options Value$40,970,853
Exercisable Options3,654,521
Exercisable Options Value$176,035,627
Total Value of Options$217,006,480
Total Number of Options4,206,009

Total Compensation*

Total Annual Cash Compensation$2,121,768
Total Short Term Compensation$1,024,524
Other Long Term Compensation$23,263
Total Calculated Compensation$33,214,929
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
UTHR:US $160.48 USD +0.24

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jeffrey M. Leiden M.D., Ph.D.Chairman, Chief Executive Officer and President
Vertex Pharmaceuticals Incorporated
$1.1M
Jean-Paul Clozel M.D.Founder, Chief Executive Officer and Director
Actelion Ltd.
SFr.2.7M
David L. Hallal Chief Executive Officer and Director
Alexion Pharmaceuticals, Inc.
$696.1K
Mark C. Rohr Chairman of the Board, Chief Executive Officer and President
Celanese Corporation
$1.1M
Shigenobu Maekawa President and Representative Director
Nippon Shinyaku Co. Ltd.
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact UNITED THERAPEUTICS CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.